𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary

✍ Scribed by Thanasak Sueblinvong; Phadet Noophun; Kamol Pataradool; Nitaya Suwanwela; Kammant Phanthumchinda; Damrong Tresukosol


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
334 KB
Volume
28
Category
Article
ISSN
1341-8076

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A 31‐year‐old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin, vinblastine and bleomycin for germ cell ovarian cancer stage Ic. The clinicoradiologic fea‐tures in this patient were consistent with posterior leukoencephalopathy, which is a rare complication of chemotherapy. Seizures were controlled by the anticonvulsive agent Dilantin (Pfizer, Khet Klongtoey, Bangkok) and she returned home without any permanent neurologic deficits. Follow‐up magnetic resonance imaging 2 weeks later showed complete resolution of the abnormalities. This syndrome has been previously reported following cisplatin‐based chemotherapy. Physicians should remain alert to the potential hazards of chemotherapy to the central nervous system. Risks and benefits should be seriously considered before starting treatment.


📜 SIMILAR VOLUMES


Germ cell malignancies of the ovary. Tre
✍ James E. Bradof; Dr. Thomas B. Hakes; Manuel Ochoa; Robert Golbey 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 3 views

Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable disease and ten (77%) had an objective response (CR o

Cisplatin and ifosfamide with either vin
✍ Fadi Farhat; Stéphane Culine; Christine Théodore; Mohamed Békradda; Marie-Josée 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

## BACKGROUND. Approximately 30% of patients with metastatic germ cell tumors require salvage chemotherapy for recurrent or refractory disease after first-line treatment. The optimal salvage chemotherapy regimen remains to be determined. ## METHODS. Fifty-four patients with metastatic germ cell